Alector (ALEC) Other Non Operating Income (2018 - 2026)
Alector (ALEC) posted quarterly Other Non Operating Income of $2.0 million for Q1 2026, down 52.91% year-over-year from $4.2 million in Q1 2025, and up 142.84% quarter-over-quarter from -$4.6 million in Q4 2025.
Alector (ALEC) Other Non Operating Income (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Other Non Operating Income for 9 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 52.91% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $3.9 million (down 82.79% YoY), while the FY2025 annual figure was $6.1 million, down 76.47% from the prior year.
- Other Non Operating Income rose to $2.0 million in Q1 2026 per ALEC's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $7.7 million in Q4 2023 and bottomed at -$4.6 million in Q4 2025.
- Historically, Other Non Operating Income has averaged $4.0 million across 5 years, with a median of $4.2 million in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 3001.65% — and 2025, when it slumped 188.9%.
- Alector's Other Non Operating Income stood at $3.8 million in 2022, then surged by 105.81% to $7.7 million in 2023, then plunged by 32.38% to $5.2 million in 2024, then plunged by 188.9% to -$4.6 million in 2025, then soared by 142.84% to $2.0 million in 2026.
- Business Quant data shows ALEC's Other Non Operating Income at $2.0 million in Q1 2026, -$4.6 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | -4.64 Mn |
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 6.21 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 7.72 Mn |
| Sep 30, 2023 | 7.36 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 5.16 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 2.33 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 121,000.00 |
| Sep 30, 2021 | 268,000.00 |